Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD IMPACT-2 (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])

NCT06215261 is registered in ClinicalTrials.gov with Transcend Therapeutics as lead sponsor.

NCT NCT06215261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06215261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD IMPACT-2 (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])
Lead sponsor
Transcend Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
April 4, 2024
Completion date
September 23, 2025
Enrollment
62 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

post traumatic stress disorder